Companies / Atea Pharmaceuticals, Inc. / Activity
Activity — Atea Pharmaceuticals, Inc.
43 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 31, 2026 | Sommadossi Jean-Pierre CEO | Other | Common Stock | $449.8K | -106K -18.49% | 467,830 0.58% of shares | low |
| Feb 3, 2026 | Sommadossi Jean-Pierre CEO | Exercise | Common Stock | $372.0K | +300K +64.13% | 767,830 0.96% of shares | low |
| Mar 11, 2026 | Corcoran Andrea Executive | Exercise | Common Stock | $74.4K | +60K +7.86% | 823,576 1.03% of shares | low |
| Jan 31, 2026 | Corcoran Andrea Executive | Other | Common Stock | $68.3K | -16K -2.07% | 763,576 0.95% of shares | low |
| Jan 31, 2026 | Horga Maria Arantxa Executive | Other | Common Stock | $68.1K | -16K -14.33% | 96,086 0.12% of shares | low |
| Jan 31, 2026 | Hammond Janet MJ Executive | Other | Common Stock | $59.9K | -14K -9.97% | 127,665 0.16% of shares | low |
| Jan 31, 2026 | Foster Wayne Executive | Other | Common Stock | $51.4K | -12K -13.26% | 79,329 0.10% of shares | low |
| Jan 31, 2026 | Vavricka John Executive | Other | Common Stock | $49.1K | -12K -12.29% | 82,594 0.10% of shares | low |
| Jun 18, 2026 | Duncan Barbara Gayle Director | Exercise | Common Stock | $0 | +30K +47.17% | 92,350 0.12% of shares | low |
| Jun 18, 2026 | Berger Franklin M Director | Exercise | Common Stock | $0 | +30K +5.84% | 536,097 0.67% of shares | low |
| Jun 18, 2026 | Duncan Barbara Gayle Director | Grant | Stock Option (Right to Buy) | — | +38K | 37,700 0.05% of shares | low |
| Jun 18, 2026 | Duncan Barbara Gayle Director | Grant | Restricted Stock Units | — | +27K | 26,700 0.03% of shares | low |
| Jun 18, 2026 | Duncan Barbara Gayle Director | Exercise | Restricted Stock Units | — | -30K -100.00% | 0 0.00% of shares | low |
| Jun 18, 2026 | Kirsch Arthur S Director | Grant | Stock Option (Right to Buy) | — | +38K | 37,700 0.05% of shares | low |
| Jun 18, 2026 | Kirsch Arthur S Director | Grant | Restricted Stock Units | — | +27K | 26,700 0.03% of shares | low |
| Jun 18, 2026 | Berger Franklin M Director | Grant | Stock Option (Right to Buy) | — | +38K | 37,700 0.05% of shares | low |
| Jun 18, 2026 | Berger Franklin M Director | Grant | Restricted Stock Units | — | +27K | 26,700 0.03% of shares | low |
| Jun 18, 2026 | Berger Franklin M Director | Exercise | Restricted Stock Units | — | -30K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Hammond Janet MJ Executive | Grant | Stock Option (Right to Buy) | — | +177K | 177,000 0.22% of shares | low |
| Jan 31, 2026 | Hammond Janet MJ Executive | Exercise | Restricted Stock Units | — | -11K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Hammond Janet MJ Executive | Exercise | Restricted Stock Units | — | -47K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Hammond Janet MJ Executive | Exercise | Common Stock | — | +58K +69.31% | 141,801 0.18% of shares | low |
| Jan 31, 2026 | Vavricka John Executive | Grant | Stock Option (Right to Buy) | — | +120K | 119,520 0.15% of shares | low |
| Jan 31, 2026 | Vavricka John Executive | Exercise | Restricted Stock Units | — | -9K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Vavricka John Executive | Exercise | Restricted Stock Units | — | -33K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Vavricka John Executive | Exercise | Common Stock | — | +42K +80.80% | 94,164 0.12% of shares | low |
| Jan 31, 2026 | Horga Maria Arantxa Executive | Grant | Stock Option (Right to Buy) | — | +174K | 173,500 0.22% of shares | low |
| Jan 31, 2026 | Horga Maria Arantxa Executive | Exercise | Restricted Stock Units | — | -10K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Horga Maria Arantxa Executive | Exercise | Restricted Stock Units | — | -42K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Horga Maria Arantxa Executive | Exercise | Common Stock | — | +51K +84.24% | 112,159 0.14% of shares | low |
| Jan 31, 2026 | Foster Wayne Executive | Grant | Stock Option (Right to Buy) | — | +108K | 108,000 0.13% of shares | low |
| Jan 31, 2026 | Foster Wayne Executive | Exercise | Restricted Stock Units | — | -8K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Foster Wayne Executive | Exercise | Restricted Stock Units | — | -33K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Foster Wayne Executive | Exercise | Common Stock | — | +41K +82.45% | 91,461 0.11% of shares | low |
| Mar 11, 2026 | Corcoran Andrea Executive | Exercise | Stock Option (Right to Buy) | — | +60K | 0 0.00% of shares | low |
| Jan 31, 2026 | Corcoran Andrea Executive | Grant | Stock Option (Right to Buy) | — | +180K | 180,000 0.22% of shares | low |
| Jan 31, 2026 | Corcoran Andrea Executive | Exercise | Restricted Stock Units | — | -11K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Corcoran Andrea Executive | Exercise | Restricted Stock Units | — | -44K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Corcoran Andrea Executive | Exercise | Common Stock | — | +55K +7.57% | 779,680 0.97% of shares | low |
| Feb 3, 2026 | Sommadossi Jean-Pierre CEO | Exercise | Stock Option (Right to Buy) | — | -300K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Sommadossi Jean-Pierre CEO | Exercise | Restricted Stock Units | — | -100K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Sommadossi Jean-Pierre CEO | Exercise | Restricted Stock Units | — | -173K -100.00% | 0 0.00% of shares | low |
| Jan 31, 2026 | Sommadossi Jean-Pierre CEO | Exercise | Common Stock | — | +273K +90.71% | 573,923 0.72% of shares | low |